Skip to main content

Closed

ACRS: Aclaris Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-961.9%

ROIC-46.8%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio4.03×

Aclaris Therapeutics, Inc.

ACRSNASDAQ Global Select·USD·Closed

Aclaris Therapeutics, Inc.

ACRSNASDAQ·USD·Closed

$5.20

−2.26%

$5.20

−$0.12 (2.26%)

52W Range

84thpctl

Volume

0.99×avg

Mkt Cap

726.25MUSD

P/E

-9.3TTM

Div Yield

–ann

52W Range

84thpctl

Volume

0.99×avg

Market Cap

726.25MUSD

P/E Ratio

-9.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings